Published in
American Society of Nephrology, Clinical Journal of the American Society of Nephrology, 2(4), p. 337-344, 2009
DOI: 10.2215/cjn.03530708
Links
- ORCID
- ORCID
- American Society of Nephrology
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease
Journal article published in 2009 by
Davide Bolignano 
,
Antonio Lacquaniti,
Giuseppe Coppolino ,
Valentina Donato,
Susanna Campo,
Maria Rosaria Fazio,
Giacomo Nicocia,
Michele Buemi
,
Antonio Lacquaniti,
Giuseppe Coppolino ,
Valentina Donato,
Susanna Campo,
Maria Rosaria Fazio,
Giacomo Nicocia,
Michele Buemi
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Background and objectives: Chronic kidney disease (CKD) has recently assumed epidemic proportion, becoming a troubling emerging cause of morbidity, especially if it progresses to terminal stage (ESRD). The authors aimed to evaluate whether neutrophil gelatinase-associated lipocalin (NGAL), a novel specific biomarker of acute kidney injury, could predict the progression of CKD.